Advertisement
Home Tags Chemotherapy

Tag: Chemotherapy

Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

0
For prevention of the delayed phase of nausea, vomiting caused by chemotherapy
A drop in carbohydrate antigen 19-9 levels of more than 10 percent after two rounds of chemotherapy is associated with longer survival in patients with advanced pancreatic ductal adenocarcinoma

Antigen Level Signals Response to Chemo for Pancreatic Cancer

0
Overall survival, time to progression longer with early drop of >10 percent in carbohydrate antigen 19-9
Diastolic dysfunction frequently develops after anthracycline chemotherapy for breast cancer

Diastolic Dysfunction Common After Anthracycline Chemo

0
BMI and age independently linked to diastolic dysfunction after anthracycline chemotherapy
Chemotherapy at the start of androgen-deprivation therapy can extend the lives of men with metastatic prostate cancer

New Rx Strategy May Up Survival in Advanced Prostate Cancer

0
Adding chemotherapy to hormone therapy added 14 months to patients' lives in study
Intraperitoneal chemotherapy significantly improves survival among women with advanced ovarian cancer; however

Intraperitoneal Chemotherapy Ups Ovarian Cancer Outcomes

0
However, only 41 percent of suitable candidates actually receive the therapy
For patients with end-stage cancer

Chemotherapy Use Doesn’t Improve QOL Near Death

0
No improvement in quality of life, even for patients with good baseline performance status
Chemotherapy dose reduction is associated with worse survival in ovarian cancer

Worse Survival With Chemo Dose Reduction in Ovarian Cancer

0
Lower average relative dose intensity linked to worse overall and ovarian cancer-specific survival
For patients with borderline resectable pancreatic adenocarcinoma (PAC) and locally-advanced PAC treated with neoadjuvant chemoradiation

Vessel Boost Tied to Improved Surgical Resection Rate

0
Findings in patients with borderline resectable, locally-advanced pancreatic cancer
Two new targeted treatments have shown promise in slowing the progression of recurring chronic-lymphocytic leukemia and slow-growing non-Hodgkin's lymphoma

ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma

0
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
Undergoing chemotherapy before surgery may help women battling advanced ovarian cancer

Benefits for Surgery Before Chemo in Advanced Ovarian CA

0
Appears to raise quality of life without shortening survival